1. Home
  2. PCRX vs FAX Comparison

PCRX vs FAX Comparison

Compare PCRX & FAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCRX
  • FAX
  • Stock Information
  • Founded
  • PCRX 2006
  • FAX 1986
  • Country
  • PCRX United States
  • FAX United States
  • Employees
  • PCRX N/A
  • FAX N/A
  • Industry
  • PCRX Biotechnology: Pharmaceutical Preparations
  • FAX Investment Managers
  • Sector
  • PCRX Health Care
  • FAX Finance
  • Exchange
  • PCRX Nasdaq
  • FAX Nasdaq
  • Market Cap
  • PCRX 604.7M
  • FAX 629.1M
  • IPO Year
  • PCRX 2011
  • FAX N/A
  • Fundamental
  • Price
  • PCRX $22.36
  • FAX $15.26
  • Analyst Decision
  • PCRX Buy
  • FAX
  • Analyst Count
  • PCRX 10
  • FAX 0
  • Target Price
  • PCRX $27.60
  • FAX N/A
  • AVG Volume (30 Days)
  • PCRX 810.1K
  • FAX 833.6K
  • Earning Date
  • PCRX 02-27-2025
  • FAX 01-01-0001
  • Dividend Yield
  • PCRX N/A
  • FAX 12.09%
  • EPS Growth
  • PCRX N/A
  • FAX N/A
  • EPS
  • PCRX N/A
  • FAX N/A
  • Revenue
  • PCRX $694,957,000.00
  • FAX N/A
  • Revenue This Year
  • PCRX $4.83
  • FAX N/A
  • Revenue Next Year
  • PCRX $2.16
  • FAX N/A
  • P/E Ratio
  • PCRX N/A
  • FAX N/A
  • Revenue Growth
  • PCRX 4.40
  • FAX N/A
  • 52 Week Low
  • PCRX $11.16
  • FAX $2.33
  • 52 Week High
  • PCRX $34.01
  • FAX $2.84
  • Technical
  • Relative Strength Index (RSI)
  • PCRX 70.92
  • FAX 48.82
  • Support Level
  • PCRX $18.18
  • FAX $14.56
  • Resistance Level
  • PCRX $22.36
  • FAX $14.95
  • Average True Range (ATR)
  • PCRX 1.13
  • FAX 0.22
  • MACD
  • PCRX 0.30
  • FAX 0.08
  • Stochastic Oscillator
  • PCRX 93.11
  • FAX 83.24

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.

About FAX abrdn Asia-Pacific Income Fund Inc.

Aberdeen Asia-pacific Income Fund Inc is a United States-based closed-end, non-diversified management investment company. Its principal investment objective is to seek current income along with capital appreciation. The fund invests in Asian debt securities, Australian debt securities, European debt securities, and others.

Share on Social Networks: